Signal active
Bio
Somu Subramaniam, is currently a Managing Partner and co-founder of New Science Ventures, a New York-based venture capital firm that invests in both early and late stage companies, using novel scientific approaches to address significant unmet needs and create order of magnitude improvements in performance.
Somu Subramaniam serves on several Boards of companies managed in New Science Venture’s portfolio, including Achronix Semiconductor Corporation, RF Arrays, Inc., Lightwire, Inc., Silicon Storage Technology, Inc., MagSil Corporation, BioVex Inc., Trellis BioScience, Inc., and BioScale, Inc.
Prior to starting New Science Ventures in 2004,Somu Subramaniam was a Director at McKinsey & Co. and at various times led their Strategy Practice, Technology Practice and Healthcare Practice. While at McKinsey, he advised leading multinational companies in the pharmaceuticals, medical devices, biotechnology, photonics, software and semiconductor industries.He was also a member of McKinsey’s Investment Committee.Somu Subramaniam received his undergraduate degree (B.Tech) from the Indian Institute of Technology and his M.B.A. from Harvard Business School.
Location
New York, New York, United States, North America
Social
Primary Organization
2004
81
29
18
1-10
Financial Services, Venture Capital, Finance
Jobs history
0
N/A
Board and Advisor Roles
3
N/A
Invest in regions
Profile Resume
Somu Subramaniam is the Co-Founder & Managing Partner at New Science Ventures, based in New York, New York, United States, North America. With a background in Financial Services, Somu Subramaniam has a rich history of leadership and innovation. Somu Subramaniam studied B.Tech unknown @ Indian Institute of Technology Bombay (IIT). Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
20
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Oct 06, 2021 | BrightVolt | Series B - BrightVolt | New Science Ventures | 16.0M |
Dec 17, 2021 | - | Series C - NorthSea Therapeutics | New Science Ventures | 80.0M |
Mar 01, 2022 | - | Series B - Paragraf | New Science Ventures | 60.0M |
Oct 05, 2023 | Glydways | Series B - Glydways | New Science Ventures | 56.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity